Yahoo Web Search

Search results

    • Small Business - Salisbury Post | Salisbury Post

      The Salisbury Post· 2 hours ago

      Virion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress PR Newswire PHILADELPHIA, June 5, 2024 Highlights from the Data

    • FDA approves Moderna’s RSV vaccine mRESVIA

      FDA approves Moderna’s RSV vaccine mRESVIA

      Pharmaceutical Technology via Yahoo Finance· 2 days ago

      In 2023, Moderna agreed to establish an mRNA manufacturing facility in Kenya. The new advanced facility will have the capacity to produce up to 500 ...

    • 1 Disruptive Biotech Stock to Buy Now, and 1 to Consider

      The Motley Fool via AOL· 2 days ago

      Nonetheless, the company has a few chances to succeed with its candidates, and it...and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P & ...